Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100214
DOI: 10.1016/j.bvth.2026.100214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von Joanne C Alfred und 1 weiteren Autor:innen. Beteiligte Einrichtung: Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
- Department of Pediatric Hematology and Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
- Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
Zitieren
APA
Alfred, J. C., & Sparkenbaugh, E. M. (2026). Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100214. https://doi.org/10.1016/j.bvth.2026.100214
Vancouver
Alfred JC, Sparkenbaugh EM. Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100214. doi:10.1016/j.bvth.2026.100214
BibTeX
@article{Alfred2026,
author = {Alfred, Joanne C and Sparkenbaugh, Erica M},
title = {Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2026},
volume = {3},
number = {4},
pages = {100214},
doi = {10.1016/j.bvth.2026.100214}
}
EUVIMED